Target intelligence / Profile preview

Ribosomal protein SA (RPSA)

Target
RPSA
Molecular classification
Receptor, Other
01

Overview

Ribosomal protein SA (RPSA), also known as the 67 kDa laminin receptor (67LR), is a multifunctional protein that plays critical roles both as a structural component of the 40S ribosomal subunit and as a high-affinity cell-surface receptor for laminin. On the cell surface, 67LR mediates cell adhesion, migration, invasion, and angiogenesis by interacting with the extracellular matrix, particularly through the laminin-derived YIGSR peptide motif. Overexpression of 67LR is strongly associated with tumor aggressiveness, metastasis, and poor prognosis in various cancers, making it an attractive therapeutic target. Additionally, 67LR serves as a receptor for several pathogens, including prions, viruses (such as Sindbis and dengue), and bacteria. The green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) acts as a natural ligand for 67LR, triggering apoptotic signaling pathways in cancer cells. Small-molecule inhibitors like NSC47924 and peptide mimetics like YIGSR are being investigated to block 67LR-mediated cell adhesion and metastasis, though targeting this receptor poses safety challenges due to its essential housekeeping role in ribosome biogenesis and protein translation.

Other names
67 kDa laminin receptor67LR37 kDa laminin receptor precursor37LRPLaminin receptor 1LAMR1LBPp40
02

Mechanism of action

Inhibition of laminin binding to block cell adhesion, migration, and metastasis, or activation of apoptotic signaling pathways to induce cancer cell death.

03

Biological functions

Signal transductionApoptosisCell proliferationCell deathOther
04

Disease associations

CancerInflammationNeurodegenerative diseaseInfectionOther
05

Safety considerations

Impairment of normal ribosomal function and protein synthesisRisk of spleen dysfunction or congenital aspleniaIncreased susceptibility to bacterial infectionsOff-target effects on translation machinery
06

Interacting drugs

2 more in the full profile.

07

Biomarkers

67LR protein expressionRPSA mRNA expression

Beyond the preview

Go deeper on Ribosomal protein SA (RPSA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein SA (RPSA).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call